Current status of surgery in dermatology.

An article titled "Current issues in dermatologic office-based surgery" was published in the JAAD in October 1999 (volume 41, issue 4, pp. 624-634). The article was developed by the Joint American Academy of Dermatology/American Society for Dermatologic Surgery Liaison Committee.

Dermabrasion: state of the art 2002.

Dermabrasion is a resurfacing procedure that has been part of dermatology for almost 100 years. With the advent of laser resurfacing in the 1990s, the art of dermabrasion has temporarily been partially eclipsed. This review article covers the history of dermabrasion, (pre-operative selection of patient equipment, the techniques and the post-operative care of dermabrasion patients.

Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl.

Voriconazole is a second-generation triazole that was approved by the Food and Drug Administration in May 2002 for treatment of severe fungal infections. In clinical trials it demonstrated superior efficacy in addition to a survival benefit when compared with the then current treatment standard, amphotericin B, for primary treatment of invasive aspergillosis. Voriconazole is a highly selective inhibitor of fungal cytochrome P450 enzymes.

Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.

Objectives: To evaluate long-term outcomes, impact of maintenance therapy and potential curability of patients with mycosis fungoides (MF) treated with psoralen plus UV-A (PUVA) monotherapy.

Design: Single-center retrospective cohort analysis.

Setting: Academic referral center for cutaneous lymphoma.